Ser203

Site Information
KRGRRKAsELRIHDL SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 38489468
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	lung cancer ( 1 , 2 , 3 ) , non-small cell lung cancer ( 1 , 2 , 3 ) , non-small cell lung adenocarcinoma ( 1 , 2 , 3 ) , non-small cell large cell lung carcinoma ( 2 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) ( 1 ) , Calu-3 (pulmonary) ( 3 ) , HCC827 (pulmonary) ( 3 ) , lung ( 1 , 2 , 3 ) , NCI-H1299 (pulmonary) ( 2 ) , NCI-H1355 (pulmonary) ( 1 ) , NCI-H1650 (pulmonary) ( 3 ) , NCI-H1734 (pulmonary) ( 2 ) , NCI-H1792 (pulmonary) ( 1 ) , NCI-H1944 (pulmonary) ( 2 ) , NCI-H1975 (pulmonary) ( 3 ) , NCI-H2106 (pulmonary) ( 3 ) , NCI-H23 (pulmonary) ( 1 ) , NCI-H358 (pulmonary) ( 2 ) , NCI-H441 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 2 )

References
1	Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
2	Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
3	Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info